ARCHIVES

Two Regorafenib Trials Demonstrate Efficacy, Improve Overall and Progression-Free Survival

This article is from The Cancer Letter archive.

Vol. 35 No. 12 | December 28, 2012

Download PDF Visit The Full Archive

Related Articles

“Imaginary Treatments,” “Wonderful Cures”

June 6, 1997

ACS Cancer Response System Budget Request Total $185,140

August 9, 1985

Hey Doc, Wanna Score Some Leucovorin? Drugs Available at 80 Times the Price

October 14, 2011

NAS To Honor Outstanding Scientists

February 28, 1997

In Brief: Sartorelli Replaces Cole As Director Of Yale Comprehensive Center; NSABP Ends Segmental Trials

March 2, 1984

Congress Passes HHS Appropriations, Includes $9 Billion for NIH, $575 Million Delayed Funding

November 15, 1991